Hernández-León C, Badial-Hernández F, Ponce-de-León A, Sierra-Madero JG

Language: Spanish
References: 31
Page: 571-578
PDF size: 279.13 Kb.

ABSTRACT

Objective. To determine the clinical and epidemiological characteristics of prison inmates with active tuberculosis in HIV-positive prison populations. Materials and methods. We conducted a cohort study in HIV-infected subjects in a prison in Mexico City, with the aim of determining clinical and epidemiological characteristics of cases with active TB. Results. We detected 172 HIV infected inmates and TB in 28 of them (16.3%) – 21 (12.2) with pulmonary TB – with an incidence rate of 7.7/100 persons/year for active TB and 4.7/100 persons/year for pulmonary TB. No drug resistance was found. Two clusters (4 and 2 subjects) were observed after RFLP-typing of 18 isolates, with a transmission rate of 11% by molecular and clinical analysis. Conclusions. The prevalence of active TB was found to be a thousand times greater than in the general population. Evidence of transmission inside the prison was also found.

REFERENCES

1. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226.

2. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-2067.

3. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-555.

4. Reyes H. Pitfalls of TB management in prisons, revisited. Int J Prison Health 2007;3:43-67.

5. Tulsky JP, White MC, Dawson C, et al. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998;88:223-226.

6. Aerts A, Habouzit M, Mschiladze L, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 2000;4:1104-1110.

7. Slavuckij A, Sizaire V, Lobera L, et al. Decentralization of the DOTS programme within a Russian penitentiary system. How to ensure the continuity of tuberculosis treatment in pre-trial detention centres. Eur J Public Health 2002;12:94-98.

8. Pleumpanupat W, Jittimanee S, Akarasewi P, et al. Resistance to antituberculosis drugs among smear-positive cases in Thai prisons 2 years after the implementation of the DOTS strategy. Int J Tuberc Lung Dis 2003;7:472-477.

9. Jittimanee SX, Ngamtrairai N, White MC, Jittimanee S. A prevalence survey for smear-positive tuberculosis in Thai prisons. Int J Tuberc Lung Dis 2007;11:556-561.

10. Secretaría de Salud. Sistema Nacional de Vigilancia Epidemiológica 2008;25:1-3.

11. Modificación a la Norma Oficial Mexicana NOM-006-SSA2-1993, para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación; 27 de septiembre de 2005. Secretaría de Salud.

12. Nolte FS, Metchock B. Murray PR, Baron EJ, Pfaller MA, Tenover FC, et al. Manual of clinical microbiology. 6th. ed. Washington, DC: ASM Press,1995:400-437.

13. Instituto Nacional de Diagnóstico y Referencia Epidemiológicas. Manual de Técnicas y Procedimientos de Laboratorio en Tuberculosis. México: Secretaría de Salud, 1992.

14. Van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-409.

15. Yang ZH, Ijaz K, Bates JH, et al. Spoligotyping and polymorphic GCrich repetitive sequence fingerprinting of Mycobacterium tuberculosis strains having few copies of IS6110. J Clin Microbiol 2000;38:3572-3576.

16. Fazel S, Baillargeon J. The health of prisoners: Review. Lancet 2011; 377: 956-965.

17. March F, Coll P, Guerrero RA, et al. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000;14:525–535.

18. Centers for Disease Control and Prevention (CDC). Rapid assessment of tuberculosis in a large prison system--Botswana, 2002. MMWR Morb Mortal Wkly Rep 2003;52:250-252.

19. Moreira-Oliveira MS, Oliveira HB, Pace F, et al. Molecular genotyping and epidemiology of Mycobacterium tuberculosis isolates obtained from inmates of correctional institutions of Campinas, Southeast Brazil. Braz J Infect Dis 2008;12:487-493.

20. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994;170:151-156.

21. Cerecer-Callú P, Aranda-Lozano JL, Márquez-Fiol AR, et al. Tuberculosis en un centro de readaptación social del noreste de México: estudio retrospectivo periodo 1999-2000, Tijuana, Baja California. Enf Inf Microbiol 2006;26:94-100.

22. García-García ML, Sifuentes-Osornio J, Jiménez-Corona ME, et al. Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program. Rev Invest Clin 2001;53:315-323.

23. Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients in Kota Bharu Hospital, Kelantan from 1998 to 2001. Southeast Asian J Trop Med Public Health 2004;35:140-143.

24. Rutta E, Mutasingwa D, Ngallaba S, Mwansasu A. Tuberculosis in a prison population in Mwanza, Tanzania (1994-1997). Int J Tuberc Lung Dis 2001;5:703-706.

25. Fernández JI, Fernández K, Catalán S, et al. Transmisión de la tuberculosis en las prisiones de Madrid. Med Clin 2000;115:246-250.

26. Koffi N, Ngom AK, Aka-Danguy E, et al. Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouake, Ivory Coast. Int J Tuberc Lung Dis 1997;1:250-253.

27. Fry RS, Khoshnood K, Vdovichenko E, et al. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. Int J Tuberc Lung Dis 2005;9:1027-1033.

28. Chiang CY, Hsu CJ, Hsu PK, et al. Pulmonary tuberculosis in the Taiwanese prison population. J Formos Med Assoc 2002;101:537-541.

29. Marco A, Caylà JA, Serra M, et al. Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 1998;12:967-971.

30. Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005;60:130-135.

31. Spradling P, Nemtsova E, Aptekar T, et al. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 2002;6:757-762.